IRCT20211110053033N1招募中未知
Determination of the safety of using allogeneic mesenchymal stem cells by pilot method in patients with cystic fibrosis referred to the Children's Medical Center
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 入组人数
- 10
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 12 years 至 18 years（—）
- 性别
- All
入选标准
- •Definitive diagnosis of cystic fibrosis
- •Severe obstructive disease defined as FEV1 / FVC less than 50%
- •Acceptable function of other organs including creatinine level less than 1.5 times normal limit in each age group, ALT level less than 135, AST level less than 3 times normal limit in each age group, bilirubin level less than 1.5 times Normal limit in any age group
- •Normal heart function on echocardiogram
- •Patients in the age range of 12 to 18 years
排除标准
- •The presence of any viral or bacterial infection that has caused pneumonia
- •Patients with Heart Failure
- •Patients with mental and physical disabilities
研究者
相似试验
招募中
1 期
Evaluation of the safety and efficacy of allogeneic activated Natural killer cells in metastatic Colon AdenocarcinomaIRCT20230704058675N1Middle East Gene Therapy corporation10
已完成
1 期
Evaluation of the safety and efficacy of allogeneic hematopoietic stem cell transplantation (HSCT) using alemtuzumab for patients with aplastic anemiaAplastic anemiaJPRN-C000000356GCP-ISS HE0403 group38
尚未招募
1 期
Assessment of the effect of allogeneic adipose derived mesenchymal stem cells along with platelet rich fibrin for perianal fistulas in treatment of perianal fistulasperianal fistula.Fistula, other specified siteM25.18IRCT20210830052332N1Iranian academic center for education culture and research24
已完成
1 期
Evaluation of the safety and efficacy of allogenic hematopoietic stem cell transplantation (HSCT) from HLA-mismatched related donors using alemtuzumab in patients with hematological malignancies.Hematological malignanciesJPRN-C000000357GCP-ISS HE0402 group48
招募中
1 期
Effect of NK cell therapy in COVID-19IRCT20200417047113N1Middle East Gene Therapy corporation70